Elkhorn Partners’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-600
Closed -$6K 51
2023
Q1
$6K Buy
+600
New +$6.65K ﹤0.01% 43
2022
Q4
Sell
-8,500
Closed -$72K 47
2022
Q3
$72K Buy
8,500
+3,800
+81% +$37.4K 0.05% 30
2022
Q2
$49K Sell
4,700
-1,100
-19% -$12.1K 0.03% 36
2022
Q1
$63K Sell
5,800
-3,600
-38% -$47.4K 0.03% 29
2021
Q4
$127K Buy
9,400
+2,700
+40% +$36.1K 0.07% 26
2021
Q3
$91K Sell
6,700
-500
-7% -$7.09K 0.06% 29
2021
Q2
$103K Sell
7,200
-1,100
-13% -$15.9K 0.06% 27
2021
Q1
$116K Buy
+8,300
New +$135K 0.07% 22

Other funds holding VTRS

Elkhorn Partners's VTRS Position: Q2 2023 in Review

Elkhorn Partners sold out of Viatris (VTRS) in Q2 2023, closing a stake of 600 shares — an estimated $6K sold.

Elkhorn Partners first reported a position in VTRS in Q1 2021 and held it in 8 quarters. The position peaked at $127K in Q4 2021. 986 funds tracked by Wall St. Rank hold VTRS as of Q2 2023.

  • Elkhorn Partners reported no remaining Viatris position as of Q2 2023 after selling out during the quarter.
  • Elkhorn Partners sold 600 Viatris shares in Q2 2023, an estimated $6K.
  • Elkhorn Partners first reported a position in Viatris in Q1 2021 and held it in 8 quarters.
  • Elkhorn Partners's Viatris position peaked at $127K in Q4 2021.
  • 986 funds tracked by Wall St. Rank held Viatris as of Q2 2023.

Based on Elkhorn Partners's 13F filing for Q2 2023, filed 14 Aug 2023.